MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive (loss)
-$5,210,702
(21.76%↑ Y/Y)
Gain (loss) from
foreign exchange...
$764,650
(150.11%↑ Y/Y)
Net (loss)
-$5,975,352
(-16.39%↓ Y/Y)
Interest income
$280,901
(-43.37%↓ Y/Y)
Foreign exchange gain
(loss)
$2,642
(105.99%↑ Y/Y)
Net (loss) before
income taxes
-$5,953,743
(-10.89%↓ Y/Y)
Provision for income taxes
$21,609
(109.20%↑ Y/Y)
Total other income
(expense)
$273,286
(-38.33%↓ Y/Y)
Revenue
$36,305,891
(4.11%↑ Y/Y)
Gain (loss) on asset
sale
-$10,257
(loss) from operations
-$6,227,029
(-7.14%↓ Y/Y)
Gross profit
$12,255,677
(14.86%↑ Y/Y)
Cost of sales
$24,050,214
(-0.64%↓ Y/Y)
Total general &
administrative expenses
$18,482,706
(12.14%↑ Y/Y)
Salaries
$7,265,346
(-5.87%↓ Y/Y)
Office
$3,864,584
(24.26%↑ Y/Y)
Intangible assets
impairment
$1,748,247
Consulting
$1,571,692
(69.88%↑ Y/Y)
Marketing
$1,143,929
(21.66%↑ Y/Y)
Accounting
$698,083
(-27.86%↓ Y/Y)
R&d
$604,308
(-35.29%↓ Y/Y)
Taxes
$469,305
(21.27%↑ Y/Y)
Director fees
$400,000
(0.00%↑ Y/Y)
Legal
$385,142
(-56.02%↓ Y/Y)
Depreciation & amortization
$332,070
(48.56%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)